Lesinurad

Lesinurad (brand name Zurampic) is a urate transporter inhibitor for treating high blood uric acid levels associated with gout.[1] It is only recommended together with either allopurinol or febuxostat when these medications are not sufficient.[2] It received FDA approval on 22 December 2015.[2] The European Commission granted a marketing authorisation valid throughout the European Union on 18 February 2016.[3] In February 2019, i... [wikipedia]